Issue 2 - Apr 14

Northern Ireland Formulary launch; New Managed Entry process for Northern Ireland; PPI volume growing despite the risks; New Jext®; Over-prescribing of liraglutide (Victoza®)? Macushield® eye supplements — not recommended for NHS supply; Reminder to practices — Leukotriene antagonists in hayfever; Valsartan (Diovan®) supply shortage